Making the invisible visible: Oncology nursing efforts of NCI-designated cancer centers in LMICs

被引:6
|
作者
Galassi, Annette [1 ]
Morgan, Camille [1 ]
Muha, Catherine [1 ]
机构
[1] US Natl Canc Inst, Ctr Global Hlth, 9609 Med Ctr Dr, Rockville, MD 20850 USA
关键词
Oncology nursing; Education and training; Healthcare workforce; Low- and middle-income countries; NCI-designated cancer centers;
D O I
10.1016/j.jcpo.2017.03.013
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
An increasing majority of new cancer cases and mortality occur in low-and middle-income countries (LMICs). Nurses provide most cancer care in LMICs, yet receive limited, if any, oncology education and training. To better understand the efforts taking place to address this need, the Center for Global Health (CGH) at the US National Cancer Institute (NCI) undertook a study of global oncology nursing projects at NCI-designated cancer centers. The 62 comprehensive and clinical NCI-designated cancer centers were surveyed about the nature and scope of their efforts in strengthening oncology nursing internationally. We received responses from 43 of the 62 cancer centers, with 21 centers reporting a total of 29 projects. Twenty-three of 29 projects had involvement in an LMIC. The most common types of projects were research studies and short-term intensive trainings, most of which were for discrete tasks. Unsurprisingly, of the projects that had specific foci, most focused on breast or cervical cancer, and palliative care. Of the 22 projects that reported project costs, almost 90% were under $200,000 USD, suggesting that strengthening the global cancer workforce can be done with limited expense. While this study is limited to efforts of NCI-designated cancer centers, the findings reveal limited engagements in education and training of oncology nurses, who provide most of the cancer care in LMICs, but also provide tangible areas for strengthening this workforce and improving oncology care delivery. Published by Elsevier Ltd.
引用
收藏
页码:34 / 37
页数:4
相关论文
共 50 条
  • [21] Assessment of readability of gynecologic cancer clinical trials literature at NCI-designated comprehensive cancer centers
    Chalif, Julia
    Khadroui, Wafa
    Vargas, Roberto
    O'Malley, David
    Chambers, Laura
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S110 - S111
  • [22] Differential survival after prostate cancer by race: Role of NCI-designated comprehensive cancer centers
    Sun, C.
    Kurian, S.
    Washington, G.
    Nielsen-Menicucci, K.
    Wilson, T.
    Crocitto, L.
    Donald, S.
    Hanby, C.
    Landier, W.
    Smith, S.
    Bhatia, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] What are NCI-designated cancer centers using for breast cancer HER2 testing?
    Siziopikou, Kalliopi P.
    Weldon, Christine B.
    Trosman, Julia R.
    Gradishar, William John
    Schink, Julian C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Blood cancer survivorship in NCI-Designated Cancer Centers: a study of services, gaps, and access barriers
    Crystal A. Reinhart
    Maria Sae-Hau
    Carol A. Lee
    Elisa S. Weiss
    Journal of Cancer Survivorship, 2020, 14 : 43 - 47
  • [25] Identifying patients for clinical trials: Evaluation of NCI-designated community cancer centers.
    Mackay, Christine B.
    Hepler, Kerry
    Erickson, Kirsten D.
    Daley, Christine
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Catchment Areas and Community Outreach and Engagement: The New Mandate for NCI-Designated Cancer Centers
    Paskett, Electra D.
    Hiatt, Robert A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (05) : 517 - 519
  • [27] A funder-based comparison of global oncology research led by NCI-designated cancer centers: Results from the 2021 global oncology survey
    Garton, Elise M.
    Eldridge, Linsey
    Cira, Mishka K.
    Frank, Allison
    Loehrer, Patrick J.
    Duncan, Kalina
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] What are NCI-designated cancer centers using for gastric and esophageal cancer HER2 testing?
    Trosman, Julia R.
    Weldon, Christine B.
    Tsongalis, Gregory J.
    Schink, Julian C.
    Benson, Al Bowen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] WHAT IT MEANS TO BE AN NCI-DESIGNATED COMPREHENSIVE CANCER CENTER
    EISNER, R
    SCIENTIST, 1990, 4 (24): : 5 - 5
  • [30] Visitation policies at NCI-designated comprehensive cancer centers during the COVID-19 pandemic
    Yeh, Jonathan C.
    Subbiah, Ishwaria M.
    Dhawan, Natasha
    Thompson, Benjamin W.
    Hildner, Zachary
    Jawed, Areeba
    Prommer, Eric
    Sinclair, Christian T.
    SUPPORTIVE CARE IN CANCER, 2021, 29 (09) : 4895 - 4898